Deadline: 2020-04-21 Status: Closed
Innovative Medicines Initiative (IMI) aims to improve health by speeding up the development of, and patient access to, innovative medicines, through the implementation of the collaboration between the key players involved in health research. The goal of IMI, particularly in its second phase (IMI2, 2014-2020) is to develop next generation vaccines, medicines and treatments, such as new antibiotics, in order to provide Europeans with more efficient and effective medicines and treatments.
In particular IMI aims to:
improve the current drug development process by providing support for the development [...]
THIS GRANT IS CURRENTLY CLOSED. SEARCH OTHER FUNDING OPPORTUNITIES OR REGISTER TO ACCESS ALL THE INFORMATION AND R&D PROJECTS OPPORTUNITIES IN YOUR AREAS OF INTEREST